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ARTICLE

Phosphorylation of IRE1 at S729 regulates RIDD in B
cells and antibody production after immunization
Chih‑Hang Anthony Tang1, Shiun Chang1, Adrienne W. Paton2, James C. Paton2, Dmitry I. Gabrilovich1, Hidde L. Ploegh3, Juan R. Del Valle4,
and Chih‑Chi Andrew Hu1

Introduction

The ER is responsible for the folding and assembly of ∼30%
of proteins encoded by our genome. Many secretory and
membrane-bound proteins are important cytokines and surface
receptors. The ER harbors complex, yet elegant, mechanisms to
control protein folding and assembly and to dispose of terminally
misfolded proteins. To respond to ER stress, the ER is equipped
with transmembrane sensors IRE1, PERK, and ATF6, representing the three major arms of the unfolded protein response (UPR),
which help cells relieve the stress and restore homeostasis (Ron
and Walter, 2007; Walter and Ron, 2011). In the case of persistent
and irreversible stress, the ER can also dictate cell death. Aberrant regulation of the UPR is implicated in many diseases (Lin et
al., 2008; Hetz et al., 2013; Hetz and Mollereau, 2014; Bettigole
and Glimcher, 2015; Chevet et al., 2015; Grootjans et al., 2016).
The ER stress sensor, IRE1, is critical for B cells. Normal B cell
development in the bone marrow requires IRE1 (Zhang et al.,
2005). Upon encountering its cognate antigen, a B cell differentiates into a plasma cell, which can produce large quantities
of high-affinity antibodies against the antigen. IRE1 is indispensable in this process because its cytoplasmic kinase/RNase
domain, upon stimulation for differentiation, can assemble into
a functional RNase that specifically splices 26 nucleotides from
mammalian XBP1 mRNA (Shen et al., 2001; Yoshida et al., 2001;
Calfon et al., 2002; Korennykh et al., 2009). The spliced XBP1
(XBP1s) mRNA encodes a functional 54-kD transcription factor,
1The Wistar Institute, Philadelphia, PA;
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XBP1s, as a result of a frame shift in translation (Calfon et al.,
2002). XBP1s up-regulates the synthesis of lipids and chaperones,
contributing to the ER expansion and increased Ig production in
plasma cells (Lee et al., 2003; Sriburi et al., 2004; McGehee et
al., 2009). In response to Toll-like receptor (TLR) ligands such as
lipopolysaccharide (LPS; a TLR4 ligand) or cytosine-phosphateguanine (CpG) DNA (a TLR9 ligand), B cells activate the IRE1–XBP1
pathway and produce large quantities of secretory IgM (sIgM;
Reimold et al., 2001; Iwakoshi et al., 2003; Hu et al., 2009a). Data
showing vastly decreased sIgM in stimulated IRE1- (Zhang et al.,
2005) and XBP1-deficient B cells (Reimold et al., 2001; Iwakoshi
et al., 2003; Hu et al., 2009a) support the role of the IRE1–XBP1
pathway in antibody production.
Other than splicing XBP1 mRNA, the RNase of IRE1 can rapidly
cleave a subset of mRNAs and so halts the production of proteins
that challenge the ER. This mechanism is known as regulated
IRE1-dependent decay (RIDD; Hollien and Weissman, 2006). We
showed previously that genetic deletion of the XBP1 gene leads to
elevated protein levels of IRE1 in B cells (Hu et al., 2009a). Recently,
the mRNA of secretory Ig μ (μS) heavy chain was shown to be an
RIDD substrate, and increased levels of IRE1 in XBP1-deficient B
cells contribute to decreased levels of sIgM by cleaving μS mRNA
(Benhamron et al., 2014). Ablation of the RNase activity of IRE1 in
XBP1-deficent B cells inhibits the RIDD of μS mRNA (Benhamron
et al., 2014). RIDD is clearly important in B cells because it protects

Downloaded from https://rupress.org/jcb/article-pdf/217/5/1739/441206/jcb_201709137.pdf by University South Florida Hsl user on 26 February 2020

To relieve endoplasmic reticulum (ER) stress, IRE1 splices XBP1 messenger RNA (mRNA) or engages regulated IRE1dependent decay (RIDD) of other mRNAs. Upon XBP1 deficiency, IRE1 switches to perform RIDD. We examined IRE1 in
XBP1-deficient B cells and discovered that IRE1 undergoes phosphorylation at S729. We generated an anti–phospho-S729
antibody to investigate such phosphorylation. Compared with pharmacological ER stress inducers or Toll-like receptor
ligands, the bacterial subtilase cytotoxin has an unusual capability in causing rapid and strong phosphorylation at S729
and triggering B cells to express spliced XBP1. To assess the function of S729 in IRE1, we generated S729A knock-in mice
and found S729 is critically important for lipopolysaccharide-stimulated plasmablasts to respond to additional ER stress
and for antibody production in response to immunization. We further crossed mice carrying an S729A mutation or ΔIRE1
(missing the kinase domain) with B cell–specific XBP1-deficient mice to trigger RIDD and discovered a critical role for
S729 in regulating RIDD in B cells.
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Results

IRE1 responded to XBP1 deficiency by undergoing
phosphorylation at S729
To investigate the role of IRE1 in XBP1-deficient B cells, we stimulated naive B cells purified from the spleens of XBP1WT and
XBP1KO mice with LPS and CpG-1826. Both LPS- and CpG-1826–
stimulated B cells produced large quantities of Ig κ light chains
(Fig. 1 A). LPS-stimulated B cells produced significantly more
sIgM than did CpG-1826–stimulated B cells. CpG-1826–stimulated
B cells produced more membrane-bound IgM. Although the
lack of XBP1 in B cells did not affect the production of membrane-bound IgM or κ light chains, it led to significantly suppressed expression of sIgM, which was attributed to increased
expression levels of IRE1 and RIDD (Fig. 1 A; Benhamron et
al., 2014). The expression level of IRE1 was up-regulated after
stimulation with LPS or CpG-1826 (Fig. 1 A; Hu et al., 2009a).
To compare the synthesis of IRE1 in LPS-stimulated XBP1proficient and -deficient B cells, we pulse-labeled the cells using
[35S]methionine and [35S]cysteine for 15 min, performed a 2-h
chase experiment in the presence of cold methionine and cysteine, and immunoprecipitated IRE1 using an anti–mouse IRE1
antibody generated in house. In contrast with XBP1-proficient B
cells, XBP1-deficient B cells produced more IRE1, which shifted
to a higher molecular weight after a 30-min chase and thereafter
(Fig. 1 B). We demonstrated that the molecular weight shift of
IRE1 was a result of phosphorylation by performing a pulse-chase
experiment coupled with digestion of the immunoprecipitated
IRE1 using λ protein phosphatase (λPPase; Fig. 1 C).
Tang et al.
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To identify the phosphorylated residues of IRE1, we immunoprecipitated IRE1 from LPS-stimulated, XBP1-deficient and
-proficient B cells using the anti–IRE1 antibody and analyzed
the immunoprecipitates by SDS-PAGE. IRE1 and other proteins
were visualized by staining with Coomassie brilliant blue (G-250;
Fig. 1 D). The band corresponding to the molecular weight of
IRE1 was excised from the gel, in-gel digested, and subjected
to peptide sequencing by liquid chromatography–tandem mass
spectrometry (LC-MS/MS). Single-peptide matches for protein
identifications and all phosphorylated peptides were further
verified by manual inspection of the tandem mass spectra (and
relatively quantified using extracted ion chromatograms [XICs]).
Most peptides detected in our LC-MS/MS analysis belonged to
IRE1. By using various enzymes (trypsin, chymotrypsin, or both
combined) for proteolytic digestion in different experiments, we
recovered peptides that covered >95% of the mouse IRE1 cytoplasmic domain sequence for a relatively thorough phosphorylation analysis. By XIC analysis, we detected clear phosphorylation
of S729 in IRE1 in response to XBP1 deficiency (Fig. 1, E and F),
with no evidence suggesting that S724 or S726 was phosphorylated in multiple LC-MS/MS analyses, and by using a commercial
antibody against phospho-S724.
To investigate the role of S729, we immunized rabbits with a
synthetic IRE1 peptide containing phosphorylated S729 residue
(Fig. 1 G) and affinity-purified anti–phospho-S729 antibodies
using exactly the same peptide. The antibodies were further
purified using a synthetic backbone peptide (Fig. 1 G) to deplete
those that recognize nonphosphorylated IRE1. To characterize our
anti–phospho-S729 antibody, we treated naive XBP1-proficient
and -deficient B cells with LPS for a course of 72 h, immunoprecipitated IRE1 using an anti–mouse IRE1 antibody, and showed
that this antibody recognizes the 130-kD phospho-IRE1 protein
produced by 48-h and 72-h LPS-stimulated XBP1-deficient B cells
(Fig. 1 H). To examine whether S729 phosphorylation occurred in
LPS-stimulated XBP1-proficient B cells, we immunoprecipitated
IRE1 from 10 times more XBP1-proficient B cell lysates so that the
backbone IRE1 became comparable with that in XBP1-deficient
B cell lysates. We did not detect S729 phosphorylation of IRE1 in
XBP1-proficient cell lysates by immunoblots (Fig. 1 I). We also
treated immunoprecipitated IRE1 with calf intestinal phosphatase
(CIP) or λPPase and showed that IRE1 did not undergo phosphorylation in LPS-stimulated XBP1-proficient B cells (Fig. 1 J), consistent with pulse-chase data (Fig. 1 B). We have shown that subtilase cytotoxin (SubAB) produced by Shiga-toxigenic Escherichia
coli specifically cleaved BiP (Paton et al., 2006) and led to phosphorylation of IRE1 (Hu et al., 2009b); however, the phosphorylated residue was not known. We treated 48-h LPS-stimulated
XBP1-proficient and -deficient B cells with SubAB for 24 h and
showed that our anti–phospho-S729 antibody recognized phosphorylated IRE1 in SubAB-treated B cells (Fig. 1 H). To confirm
the phosphospecificity of our anti–phospho-S729 antibody, we
treated 5TGM1 mouse multiple myeloma cells with SubAB immunoprecipitated IRE1 using an anti–IRE1 antibody and incubated
immunoprecipitated IRE1 with λPPase or CIP before immunoblotting using the anti–phospho-S729 antibody. This antibody recognized phosphorylated IRE1 in SubAB-treated 5TGM1 cells and did
not react with that preincubated with λPPase or CIP (Fig. 1 K).
Journal of Cell Biology
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XBP1-deficient B cells from accumulating unfolded proteins in the
ER by degrading μS mRNA, which encodes one of the most abundant ER proteins in B cells. Enhanced RIDD in response to XBP1
deficiency is also critical in regulating proinsulin processing and
insulin secretion in pancreatic β-cells (Lee et al., 2011), protecting
hepatocytes from acetaminophen-induced hepatotoxicity (Hur
et al., 2012) and suppressing lipogenesis and lipoprotein metabolism (So et al., 2012). In response to prolonged ER stress, RIDD
is responsible for the decay of specific microRNAs that repress
translation of the caspase-2 mRNA, causing drastically elevated
levels of caspase-2 (Upton et al., 2012).
We identified that IRE1 is phosphorylated at S729 in XBP1-deficient mouse B cells. By generating and using a specific anti–
phospho-S729 antibody, we confirmed that S729 is indeed
phosphorylated in XBP1-deficient B cells and discovered that
phosphorylation of S729 only occurs under certain ER stress
conditions. Next, we generated a knock-in mouse model, S729A,
and showed that, although B cells from mice carrying the S729A
mutation can respond to LPS-stimulated B cell differentiation by
producing XBP1s, they fail to respond to additional pharmacologic or bacterial toxin insults. To investigate the role of S729 and
the kinase domain of IRE1 in regulating RIDD, we crossed S729A
and IRE1f/f mice with B cell-specific XBP1 knockout (KO; XBP1KO;
CD19Cre/XBP1f/f ) mice to trigger RIDD. Our results showed that
S729 phosphorylation of IRE1 is critical for enhancing the splicing of XBP1 mRNA and engaging RIDD in cultured B cells and
plasma cells in immunized mice.
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SubAB was potent in inducing S729 phosphorylation of IRE1,
which could be rapidly suppressed by KIRA6
To investigate the role of S729 phosphorylation, we treated 5TGM1
cells with DTT, brefeldin A (BFA), B-I09 (an IRE1 RNase inhibitor;
Tang et al., 2014), MG132, SubAB, thapsigargin (Tg), or tunicamycin
Tang et al.
Phosphorylation at S729 of IRE1 regulates RIDD

Downloaded from https://rupress.org/jcb/article-pdf/217/5/1739/441206/jcb_201709137.pdf by University South Florida Hsl user on 26 February 2020

Figure 1. IRE1 is phosphorylated at S729 in
XBP1-deficient B cells. (A) Naive XBP1WT and
XBP1KO B cells were stimulated with LPS (20 µg/
ml) or CpG-1826 (0.5 µM) for 3 d. Lysates were
immunoblotted for indicated proteins. (B) 3-d
LPS-stimulated XBP1WT and XBP1KO B cells were
starved in cysteine- and methionine-free media
for 1 h, radiolabeled for 15 min, and chased for
a course of 2 h. Lysates were immunoprecipitated (IP) for IRE1, which was then analyzed by
SDS-PAGE and autoradiography. (C) 3-d LPSstimulated XBP1KO B cells were starved for 50
min, radiolabeled for 10 min, and chased. Lysates
were immunoprecipitated for IRE1, which was
boiled in 1% SDS containing 5 mM DTT, further
diluted to contain 0.05% SDS and 0.5% NP-40,
and reimmunoprecipitated using the same anti–
IRE1 antibody. Bead-bound IRE1 was further
treated with λPPase for 3 h and analyzed by SDSPAGE and autoradiography. (D) LPS-stimulated
XBP1WT and XBP1KO B cell lysates were immunoprecipitated for IRE1, analyzed by SDS-PAGE, and
stained with Coomassie brilliant blue G-250. The
closed triangle marks IRE1, confirmed by LC-MS/
MS sequencing. HC, IgG heavy chains; LC, IgG
light chains; M, molecular weight. (E) The unmodified peptide, aa 726–743, was detected as a triply protonated molecule at m/z 648.3312 (−0.71
ppm error) and assigned with a MASCOT score
of 50. (F) The corresponding phosphopeptide
was detected at 674.9878 (−1.3 ppm error) with
a MASCOT score of 35. The ions in the tandem
spectra are labeled and marked in the sequence.
S indicates the phosphorylation. (G) Amino acid
sequences of the phosphopeptide and backbone
peptide of IRE1 for generation and purification of
the anti–phospho-S729 antibody. (H) XBP1WT and
XBP1KO B cells were stimulated with LPS for 72 h.
Some LPS-stimulated B cells were exposed to
SubAB in the last 24 h of the time course. Lysates
were immunoblotted for the indicated proteins
or immunoprecipitated with an anti–mouse IRE1
antibody before immunoblotting with the anti–
phospho-S729 antibody. (I) XBP1WT and XBP1KO B
cells were stimulated with LPS for 72 h. 10 times
more XBP1WT B cell lysates were used for immunoprecipitation for IRE1, which was then immunoblotted with the anti–phospho-S729 antibody.
IRE1 and p97 immunoblots are input controls. (J)
3-d LPS-stimulated XBP1WT and XBP1KO B cells
were lysed and immunoprecipitated for IRE1.
Bead-bound IRE1 was treated with CIP or λPPase
for 3 h and immunoblotted for IRE1. (K) 5TGM1
myeloma cells were exposed to SubAB for 16 h.
Lysates were immunoprecipitated for IRE1. Beadbound IRE1 was treated with λPPase or CIP for 3 h
and immunoblotted for the indicated proteins.
The p97 immunoblot is an input control. Data
in this figure are representative of at least three
independent experiments. WB, Western blot.

(Tu; Fig. 2 A). We performed time-course experiments using
5 mM DTT, based on our result showing that 5 mM DTT induced
the highest phosphorylation at S729 of IRE1 in dose-dependent
experiments, and observed that S729 phosphorylation occurred
at the 45-min time point, whereas significantly increased XBP1s
Journal of Cell Biology
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occurred at the 3-h time point (Fig. 2, B and C). We then performed
time-course and dose-dependent experiments for SubAB (Fig. 2, D
and E), Tg (Fig. S1, A and B), Tu (Fig. S1, C and D), BFA (Fig. S1, E and
F), and MG132 (Fig. S1, G and H) and compared results with those
treated with 5 mM DTT for 3 h in all experiments. Compared with
DTT, 1.5 nM SubAB cleaved BiP and induced increased synthesis
and phosphorylation of IRE1 accompanied by the expression of
XBP1s in the course of 24-h treatment (Fig. 2 D). Phosphorylation of
S729 was also detected in experiments using lower concentrations
of SubAB (Fig. 2 E). Tg induced S729 phosphorylation to a much
lesser degree than DTT in both time-course and dose-dependent
experiments (Fig. S1, A and B). In repeated time-course and
dose-dependent experiments, we did not detect S729 phosphorylation in cells treated with Tu (Fig. S1, C and D), BFA (Fig. S1, E and
F), or MG132 (Fig. S1, G and H). 5TGM1 cells treated with MG132
expressed reduced levels of IRE1 after 4 h (Fig. S1 G) because of
Tang et al.
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rapid apoptosis but not lysosomal degradation (Fig. S1 I); however,
those treated with BFA or Tu at least maintained, if not increased,
the expression levels of IRE1 (Fig. S1, C–F). Untreated 5TGM1 cells
as well as those treated with Tu, BFA, or MG132 all expressed XBP1s
despite the lack of S729 phosphorylation (Fig. S1, C–H), suggesting
that S729 phosphorylation of IRE1 was not required for initial activation of XBP1s. We immunoprecipitated IRE1 from untreated as
well as Tu- and BFA-treated 5TGM1 cells, dephosphorylated IRE1
using CIP, and showed that IRE1 in untreated or Tu- or BFA-treated
5TGM1 cells was phosphorylated at other sites (Fig. S1, J and K).
KIRA6, an IRE1 kinase inhibitor, was shown to inhibit IRE1
from splicing XBP1 mRNA and cleaving insulin mRNA (Ghosh
et al., 2014). We tested whether KIRA6 could affect S729 phosphorylation of IRE1 by treating 5TGM1 cells with SubAB in the
presence of increasing concentrations of KIRA6 for 12 h (Fig. S2
A). KIRA6 suppressed SubAB-induced S729 phosphorylation of
Journal of Cell Biology
https://doi.org/10.1083/jcb.201709137
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Figure 2. DTT and SubAB induce IRE1 to
undergo strong and rapid phosphorylation at
S729. (A) 5TGM1 cells were treated with 5 mM
DTT for 3 h or with 3.5 µM BFA, 20 µM B-I09,
50 µM MG132, 1 nM SubAB, 2.5 µM Tg, or 5 µg/ml
Tu for 12 h. Lysates were immunoblotted for the
indicated proteins. (B) 5TGM1 cells were treated
with 5 mM DTT for the indicated times and immunoblotted. (C) 5TGM1 cells were treated with
DTT at the indicated concentrations for 3 h and
immunoblotted. (D) 5TGM1 cells were treated
with 5 mM DTT for 3 h or with 1.5 nM SubAB for
24 h and immunoblotted. (E) 5TGM1 cells were
treated with 5 mM DTT for 3 h or with SubAB for
12 h using increasing concentrations and immunoblotted. (F) 5TGM1 cells were exposed to 1 nM
SubAB for 12 h and were subsequently treated
with KIRA6, staurosporine, imatinib, or sunitinib
at 5 µM for an additional 2 h and then immunoblotted. Data in this figure are representative of
three independent experiments.
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IRE1 in a dose-dependent manner, with little impact on the levels of XBP1s. In addition, we treated 5TGM1 cells with SubAB for
12 h and then exposed such cells to 5 µM KIRA6 for a course of
8 h (Fig. S2 B). KIRA6 rapidly suppressed S729 phosphorylation
without affecting the levels of XBP1s. KIRA6 also did not suppress
phosphorylation of IRE1 at other sites (Fig. S2 C). Compared with
staurosporine (a broad-spectrum kinase inhibitor that binds to
IRE1; Concha et al., 2015), imatinib (a tyrosine kinase inhibitor
that activates IRE1 in cardiomyocytes; Kerkelä et al., 2006), or
sunitinib (a receptor tyrosine kinase inhibitor that binds to IRE1;
Korennykh et al., 2009; Ali et al., 2011), KIRA6 was effective in
suppressing S729 phosphorylation of IRE1 (Figs. 2 F and S2 D).

Generation of the S729A knock-in mouse model
To investigate the physiological role of the S729 residue of IRE1,
we generated a novel knock-in mouse model, S729A (Fig. S3 A).
We confirmed the long- and short-arm integration of the targeting vector by Southern blots (Fig. S3 A) and the presence of the
desired mutation in the IRE1 gene by DNA sequencing. Purified
B cells from WT and S729A mice were cultured in the presence
of LPS for 3 d, radiolabeled for 4 h, and chased for a course of 8 h
in the absence or presence of SubAB, and the immunoprecipitation results confirmed that LPS could not trigger IRE1 to undergo
phosphorylation at S729 in WT B cells, but SubAB could (Fig. 4 A).
The percentages of B and T cells changed slightly in
S729A knock-in mice
To examine B cell development in the bone marrow of S729A
mice, we analyzed gated B220+ B cell progenitors for CD43+/
Tang et al.
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Immunized S729A mice generated less CD138+ plasma cells,
which expressed lower levels of XBP1s
To compare the expression levels of XBP1s in plasma cells from
immunized WT and S729A mice, we characterized a recently
developed anti-XBP1s mouse monoclonal antibody. This antibody
recognized human XBP1s expressed by H929 myeloma cells stimulated with DTT and mouse XBP1s produced by A20 B cell lymphoma upon SubAB stimulation (Fig. 4, B and C). As a negative
control for this antibody, B-I09 abolished SubAB-induced expression of XBP1s in A20 cells (Fig. 4 C). We stained bone marrow cells
from HEL-immunized WT and S729A mice for CD138, B220, and
XBP1s and found that CD138+ plasma cells indeed produced higher
levels of XBP1s than B220+ B cell progenitors (Fig. 4 D). When comparing immunized WT and S729A mice, we found decreased percentages of CD138+ plasma cells in the bone marrow of S729A mice
(Fig. 4, D and E) and significantly lower mean fluorescence intensity (MFI) of XBP1s expressed by CD138+ plasma cells in immunized S729A mice (Fig. 4 F). We also found decreased percentages of CD138+ plasma cells in spleens of immunized S729A mice
(Fig. 4 G), and these plasma cells similarly expressed lower levels
of XBP1s (Fig. 4 H). Despite the reduced percentages of plasma cells
in HEL-immunized S729A mice, serum levels of anti–HEL IgG or
IgG1 remained unabated (Fig. 4, I and J).
Journal of Cell Biology
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SubAB but not other AB5 toxins induced S729
phosphorylation of IRE1
Cytotoxicity of SubAB is a result of BiP cleavage at a dileucine
motif (Leu417 and Leu418 in mouse BiP); overexpression of BiP
in which the SubAB cleavage site is eliminated can protect cells
from SubAB-induced cytotoxicity (Paton et al., 2006). To demonstrate that SubAB induced S729 phosphorylation through cleaving BiP, we treated 5TGM1 cells with a mutant SubAA272B carrying
a single serine-to-alanine substitution at the critical Ser272 in
the catalytic triad (Asp-His-Ser) of its A subunit and showed that
only native SubAB cleaved BiP and caused S729 phosphorylation
of IRE1 (Fig. 3 A). Other than SubAB, there are three types of AB5
toxins: Shiga toxins 1 and 2 from Shigella dysenteriae and E. coli,
cholera toxin from Vibrio cholera, and pertussis toxin from Bordetella pertussis. Similar to SubAB, all three AB5 toxins enter the
ER through retrograde transport. Although SubAB cleaves BiP in
the ER, the other AB5 toxins need to be retrotranslocated from
the ER into the cytoplasm to exert their toxic effects. We treated
5TGM1 cells with Shiga toxins 1 and 2 (Figs. 3 B and S2 E), cholera toxin (Figs. 3 C and S2 F), or pertussis toxin (Figs. 3 D and S2
G) and investigated the capabilities of these toxins in inducing
S729 phosphorylation of IRE1. Even when we treated 5TGM1 cells
with 10 times more concentrated Shiga toxins, cholera toxin or
pertussis toxin than 1 nM SubAB, we did not detect S729 phosphorylation of IRE1 (Fig. S2, E–G). However, we observed slightly
increased expression of XBP1s in Shiga toxin–, cholera toxin–,
and pertussis toxin–treated cells (Fig. 3, B–D).

CD19low pro–B cells and CD43+/CD19high pre–B cells (Fig. S3 B,
middle) and detected little change in the percentages of B cell
progenitors, pro–, or pre–B cells when comparing unimmunized
S729A with WT mice (Fig. S3, B–E). We also gated the CD43−/
CD19+ population and analyzed them for IgM+/IgD− immature B
cells and IgM+/IgD+ mature B cells in the bone marrow (Fig. S3
B, right), and we found that S729A mice exhibit similar percentages of immature and mature B cells when compared with WT
mice (Fig. S3, F and G). WT and S729A mice were also immunized
with hen egg lysozyme (HEL), emulsified in complete Freund’s
adjuvant (CFA), and boosted three times with HEL plus incomplete Freund’s adjuvant (IFA). We observed increased numbers
of pro– and mature B cells in the bone marrow of S729A mice
(Fig. S3, D and G).
In the spleens of unimmunized and HEL-immunized mice,
we analyzed the gated CD19+ B cell population and detected no
difference of this population between WT and S729A mice (Fig.
S4, A and B). We next gated CD3+ populations to analyze for CD4+
and CD8+ T cells. Normal CD4/CD8 T cell ratio and T cell percentages were found in unimmunized WT and S729A mice (Fig. S4,
A, C, and D); however, increased percentages of CD4+ and CD8+ T
cells were observed in immunized S729A mice (Fig. S4, C and D).
We also analyzed the gated CD19+/B220+/GL7−/AA4.1− B cell population for CD1d+/CD23− marginal zone B cells and CD1d−/CD23+
follicular B cells in spleens and found no difference between
unimmunized and immunized WT and S729A mice (Fig. S4, E–G).
In peripheral lymph nodes of unimmunized and HEL-immunized mice, we analyzed the gated CD19+ B cell population and
found decreased percentages of this population in immunized
S729A mice (Fig. S4, H and I). We also analyzed the gated CD3+
populations for CD4+ and CD8+ T cells and detected increased CD4
and CD8 T cell percentages in the lymph nodes of immunized
S729A mice (Fig. S4, H, J, and K).
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Figure 3. SubAB, but not other AB5 toxins, cleaves BiP and
induces S729 phosphorylation of IRE1. (A) 5TGM1 cells were
treated with mutant or native SubAB for 24 h using increasing concentrations and immunoblotted. (B) 5TGM1 cells were
treated with 1 nM SubAB, 1 nM Shiga toxin 1, or 1 nM Shiga toxin
2 for 24 h and immunoblotted. Phospho–NF-κB p65 served as a
control for the activity of the Shiga toxins. (C) 5TGM1 cells were
treated with 1 nM SubAB for 24 h or with 1 nM cholera toxin for
24 h and immunoblotted. Phospho-ERK1/2 and phospho–NF-κB
p105 served as controls for the activity of the cholera toxin.
(D) 5TGM1 cells were treated with 1 nM SubAB or 1 nM pertussis
toxin for 24 h and immunoblotted. Phospho–NF-κB p65 served
as a control for pertussis toxin activity. Data in this figure are
representative of three independent experiments.

Tang et al.
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WT B cells, S729A B cells expressed slightly lower levels of XBP1s
(Fig. 5, C and D), consistent with our immunoblot data (Fig. 5 A).
To explore how S729A B cells responded to additional ER
insults, we exposed 2-d LPS-stimulated WT and S729A B cells to
DTT for 3 h or to Tg or SubAB for 3, 6, 12, and 24 h, and monitored the percentages of XBP1s-expressing B cells and the MFI of
XBP1s by flow cytofluorometry (Fig. 6, A–C; and Fig. S5, A and B).
As a negative control, LPS-stimulated B cells were treated with
B-I09 to shut down the expression of XBP1s (Fig. 6 A). Compared
with DTT or Tg (Fig. 6, A and B; and Fig. S5 A), SubAB triggered
most of the LPS-stimulated WT B cells to further express XBP1s,
resulting in much higher MFI (Figs. 6 C and S5 B). However, all
these ER stress inducers failed to trigger LPS-stimulated S729A
B cells to further express XBP1s (Fig. 6, A–C; and Fig. S5, A and
B), and we confirmed such results by immunoblots (Fig. 6 D). In
addition, IRE1 immunoprecipitated from SubAB- and DTT- but
Journal of Cell Biology
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S729A B cells responded to LPS by producing XBP1s but could
not respond to additional ER insults by up-regulating the
levels of XBP1s
To further analyze B cell differentiation, we purified naive B
cells from S729A mice, stimulated them with LPS, and found
that S729A B cells can express XBP1s, albeit at decreased levels
(Fig. 5 A). By analyzing LPS- or CpG-1826–stimulated B cells
stained with the anti-XBP1s antibody, we realized for the first
time that not all naive B cells can respond to LPS or CpG-1826
by producing high levels of XBP1s (Fig. 5 B). Compared with
CpG-1826, LPS induced significantly more B cells to produce
XBP1s during 3 d of stimulation (Fig. 5 B), consistent with our
immunoblot data (Fig. 1 A). Next, we stimulated B cells purified
from S729A mice with LPS for 24 h and monitored the percentages of cells that expressed XBP1s as well as the MFI of XBP1s
by flow cytofluorometry for an additional 24 h. Compared with
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not Tg-treated S729A B cells could be further dephosphorylated
with CIP (Fig. 6 E), suggesting that SubAB and DTT could also
induce phosphorylation of IRE1 at sites different from S729.
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Figure 4. HEL-immunized S729A mice generate significantly less CD138+ plasma cells in the spleens and bone marrow, and those plasma cells express
less XBP1s. (A) 3-d LPS-stimulated WT and S729A B cells were radiolabeled for 4 h and chased in the absence or presence of 1 nM SubAB for a course of 8 h.
Lysates were immunoprecipitated for IRE1, which was then analyzed by SDS-PAGE and autoradiography. (B) Human H929 cells were treated with 5 mM DTT
for 3 h and immunoblotted. (C) Mouse A20 cells were pretreated with 20 µM B-I09 for 12 h, were subsequently exposed to 1.5 nM SubAB for 12 h, and were
immunoblotted. (D) WT and S729A mice were immunized with HEL plus CFA and boosted three times with HEL plus IFA. Bone marrow cells isolated from
immunized mice were stained for CD138, B220, and XBP1s. Gated B220+ and CD138+ populations were analyzed for expression of XBP1s. FSC-A, forward scatter
area. (E) Percentages of CD138+ plasma cells in the bone marrow of HEL-immunized WT and S729A mice. (F) MFI of XBP1s in CD138+ plasma cells in the bone
marrow of HEL-immunized WT and S729A mice. (G) Percentages of CD138+ plasma cells in spleens of HEL-immunized WT and S729A mice. (H) MFI of XBP1s
in CD138+ plasma cells in spleens of HEL-immunized WT and S729A mice. (I and J) Serum levels of anti–HEL IgG (I) and IgG1 (J) in immunized WT and S729A
mice were determined by ELISA. Data are shown as means ± SEM.

Nevertheless, in the face of S729A mutation, the enhanced
expression of XBP1 in response to SubAB or DTT was completely
blocked (Fig. 6, A, C, and D).
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Phosphorylation at S729 of IRE1 was responsible for RIDD
XBP1 deficiency leads to the up-regulated levels of IRE1 and RIDD
in liver, pancreas, and B cells (Lee et al., 2011; Hur et al., 2012; So
et al., 2012; Benhamron et al., 2014). In XBP1-deficient B cells,
μS mRNA is destroyed by RIDD, which leads to significantly
decreased levels of sIgM (Benhamron et al., 2014). To test the
potential contribution of S729 phosphorylation of IRE1 to RIDD,
we crossed S729A mice with B cell–specific XBP1KO (CD19Cre/
Tang et al.
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Figure 5. S729A B cells respond to LPS or CpG-1826 stimulation by producing XBP1s. (A) Naive WT and S729A B cells were stimulated with LPS (20 µg/
ml) for a course of 3 d and immunoblotted. (B) Naive WT B cells were stimulated with LPS or CpG-1826 (0.5 µM) for a course of 3 d, stained for XBP1s and B220,
and analyzed for gated B220+/XBP1s+ populations. (C) B cells purified from WT and S729A mice were stimulated with LPS for 1 d and continued to be stimulated
with LPS for an additional 3, 6, 12, and 24 h (the end of day 2). At each time point, B cells were stained for XBP1s and B220 and were analyzed for gated B220+/
XBP1s+ populations. Flow cytofluorometric data are representative of three independent experiments. (D) Naive B cells purified from WT (n = 3) and S729A
(n = 3) mice were stimulated with LPS for 1 d and continued to be stimulated with LPS for an additional 3, 12, and 24 h. At each time point, B cells were stained
with XBP1s–Alexa Fluor 647 and B220–Alexa Fluor 488. The gated B220+ populations were analyzed for expression of XBP1s shown as MFI (means ± SD). The
MFI data are representative of three independent experiments.

XBP1f/f ) mice to generate S729A/XBP1KO mice. As critical controls, we generated B cell–specific IRE1KO mice by crossing IRE1f/f
mice (Zhang et al., 2011) with CD19Cre mice. CD19Cre/IRE1f/f
mice were further crossed with XBP1f/f mice to generate B cell–
specific IRE1KO/XBP1KO (CD19Cre/IRE1f/f/XBP1f/f ) mice. We purified B cells from spleens of WT, XBP1KO, IRE1KO, IRE1KO/XBP1KO,
S729A, and S729A/XBP1KO mice and stimulated those B cells with
LPS for 3 d (Fig. 7, A and B). Upon LPS stimulation, IRE1KO and
Journal of Cell Biology
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Figure 6. LPS-stimulated S729A B cells fail to respond to secondary ER stress by producing additional XBP1s. (A) 2-d LPS-stimulated WT and S729A B cells
were exposed to 20 µM B-I09 or 5 mM DTT for 3 h, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (B) 2-d LPS-stimulated WT and S729A B
cells were exposed to 2.5 µM Tg for the indicated times, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (C) 2-d LPS-stimulated WT and S729A
B cells were exposed to 1.5 nM SubAB for the indicated times, stained for XBP1s and B220, and gated for B220+/XBP1s+ populations. (D) 2-d LPS-stimulated WT
and S729A B cells were exposed to 1 nM SubAB, 5 µg/ml Tu, or 2.5 µM Tg for 12 h or were exposed to 5 mM DTT for 3 h and immunoblotted. (E) 2-d LPS-stimulated
WT and S729A B cells were exposed to 1 nM SubAB or 2.5 µM Tg for 12 h or were exposed to 5 mM DTT for 3 h, lysed, and immunoprecipitated for IRE1. Bead-bound
IRE1 was treated with CIP for 3 h and immunoblotted for IRE1. Data in this figure are representative of three independent experiments.
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SubAB induced RIDD in B cells
Because SubAB triggered S729 phosphorylation effectively
(Fig. 2, A, D, and E), we tested whether SubAB could induce RIDD
in B cells. We exposed LPS-stimulated WT and S729A B cells to
SubAB for 24 h and confirmed that SubAB induced these B cells
to express high levels of Hspa5 (BiP) and Pdia4 (protein disulfide isomerase A4) mRNAs (Fig. 8, A and B). Congruent with our
flow cytofluorometry data (Figs. 6 C and S5 B), SubAB induced
LPS-stimulated S729A B cells to express less XBP1s mRNA than
LPS-stimulated WT B cells (Fig. 8 C). SubAB indeed induced
RIDD as shown by the decreased levels of μS mRNA in WT but
not S729A B cells upon SubAB treatment (Fig. 8 D). Because Tu
did not cause phosphorylation of S729 (Figs. 2 A and S1, C and D),
we also found that it did not induce RIDD of μS mRNA in B cells
(Fig. 8 E). We further investigated the response of other RIDD
substrates in SubAB-treated WT and S729A B cells (Fig. 8, F–J).
Similar to μS mRNA results (Fig. 8 D), SubAB induced RIDD of
these mRNA substrates in WT B cells but less so in S729A B cells
(Fig. 8, F–J).
B-I09 and KIRA6 inhibited RIDD in XBP1-deficient B cells
B-I09 inhibits IRE1 from splicing the XBP1 mRNA (Figs. 2 A, 4 C,
and 6 A; Tang et al., 2014). We tested whether B-I09 could also
inhibit RIDD. B-I09 efficiently blocked the degradation of μS
mRNA in XBP1-deficient B cells (Fig. 8 K), suggesting that B-I09
was also an inhibitor of RIDD. KIRA6 has a better activity in inhibiting IRE1 from cleaving insulin mRNA (an RIDD substrate) than
from splicing the XBP1 mRNA (Ghosh et al., 2014). Intrigued by
our results showing that KIRA6 inhibited S729 phosphorylation
Tang et al.
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and had little effect in suppressing the expression of XBP1s (Figs.
2 F and S2, A–D), we hypothesized that KIRA6 could inhibit the
degradation of μS mRNA in XBP1-deficient B cells and showed
that this was indeed the case (Fig. 8 L).
Immunized S729A mice produced increased amounts of IgM
and IgG2b in the blood
To explore the role of S729 in vivo, we immunized WT, XBP1KO,
S729A, and S729A/XBP1KO mice with NP-Ficoll to interrogate B
cell–intrinsic role of S729. B cells respond to such immunization
by producing NP-specific IgM. We analyzed NP-specific IgM levels in sera at 3, 6, and 9 d after immunization (Fig. 9, A–C) and
detected significantly increased IgM levels in S729A mice on
day 6, when compared with WT mice (Fig. 9 B). When we compared immunized S729A/XBP1KO with XBP1KO mice, we detected
consistently increased levels of IgM and increased frequencies of NP-specific plasma cells in S729A/XBP1KO mice (Fig. 9,
A–D). Although we did not detect a significant difference in NPspecific plasma cell frequencies between immunized WT and
S729A mice (Fig. 9 D), the expression levels of XBP1s were significantly lower in plasma cells of immunized S729A mice
(Fig. 9 E). Such data support the hypothesis that S729A mutation
compromises IRE1’s function in splicing XBP1 mRNA, leading to
decreased levels of XBP1s, and in cleaving μS mRNA, leading to
increased levels of IgM.
Although we did not detect significantly increased anti–HEL
IgG or IgG1 in S729A mice repeatedly immunized with HEL
(Fig. 4, I and J), such immunization allowed further class-switch
recombination. As demonstrated, the γ2b mRNA is an RIDD substrate (Benhamron et al., 2014). We examined anti–HEL IgG2b
levels in repeated immunized WT and S729A mice and found significantly increased serum levels of IgG2b in immunized S729A
mice (Fig. 9 F), supporting the idea that plasma cells of immunized S729A mice acquired defective RIDD.

Discussion

The kinase domain of IRE1 is critical for the RNase activity of
IRE1 as demonstrated by our data showing that missing aa 652–
751 in the kinase domain completely blocks the expression of
XBP1s in LPS-stimulated B cells (Fig. 7 A); however, IRE1 carrying the S729A mutation can still express XBP1s (Figs. 5 A and 7 B).
In XBP1KO B cells, up-regulated IRE1 undergoes phosphorylation
at S729 (Fig. 1, F and H) and contributes to RIDD (Fig. 10). This
is supported by the results showing that the S729A mutation
can inhibit IRE1 from cleaving RIDD substrates in XBP1KO B cells
(Fig. 7, B–F). In contrast with inhibiting RIDD in XBP1KO B cells
by deleting the RNase activity of IRE1 (Benhamron et al., 2014),
our data showed that deleting the kinase function or mutating
S729 in the kinase domain of IRE1 was sufficient to block RIDD in
XBP1KO B cells (Fig. 7, A–F). Distinct from the two different B cell–
specific IRE1KO mouse models in which both XBP1 splicing and
RIDD are blocked (Fig. 7, A, C, E, and F; Benhamron et al., 2014),
the S729A mutation only blocks RIDD (Fig. 7, B–F), highlighting
the critical function of S729 in regulating RIDD in B cells. When
we immunized WT and S729A mice with a T-independent antigen (NP-Ficoll), we detected increased levels of anti–NP IgM in
Journal of Cell Biology
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IRE1KO/XBP1KO B cells produced a 115-kD ΔIRE1 protein, which
lacked 100 amino acids (from aa 652 to aa 751) in the kinase
domain (Fig. 7 A). Consistent with previous studies, the lack of
XBP1s caused normal and leukemic B cells to produce up-regulated levels of IRE1 (Fig. 7 A; Hu et al., 2009a; Tang et al., 2014),
contributing to the increased RIDD (Benhamron et al., 2014)
and decreased protein levels of the μS chains (Fig. 7 A). The
lack of functional IRE1 in IRE1KO and IRE1KO/XBP1KO B cells abolished RIDD, allowing B cells to continue synthesizing μS chains
(Fig. 7 A). LPS-stimulated S729A B cells produced XBP1s and synthesized μS chains, and LPS-stimulated S729A/XBP1KO B cells also
up-regulated the S729-mutated IRE1 protein (Fig. 7 B). Notably,
the S729A mutation, similar to IRE1KO, abolished RIDD, resulting
in increased expression of μS mRNA and μS chains in S729A/
XBP1KO B cells (Fig. 7, A–D). In addition, the S729A mutation and
IRE1KO almost completely blocked RIDD of Tapbp1 and Hgsnat
mRNAs in XBP1KO B cells (Fig. 7, E and F). Although both S729A
and IRE1KO abolished RIDD to allow for the recovery of μS chains,
we did not observe a complete recovery of μS mRNA levels, suggesting that RIDD was not the only mechanism that caused the
degradation of μS mRNA in XBP1-deficient B cells (Fig. 7 C).
To further confirm that S729 phosphorylation played a role in
regulating RIDD, we transfected IRE1−/− mouse embryonic fibroblasts (MEFs) with IRE1 carrying phosphomimetic mutations
(S729D and S729E) and showed that these cells expressed significantly less mRNA levels of RIDD substrates when compared with
those transfected with WT IRE1 (Fig. 7, G–M).
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S729A mice (Fig. 9, A–C). In mice repeatedly immunized with
a T-dependent antigen (HEL), we also detected significantly
increased IgG2b levels in S729A mice (Fig. 9 F). Such data suggest that S729 phosphorylation on IRE1 is critical for plasma cells
to curtail the production of IgM and certain Ig isotypes such as
IgG2b in response to immunization.
Tang et al.
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Figure 7. Phosphorylation at S729 of IRE1 is critical for RIDD. (A) WT, XBP1KO, IRE1KO, and IRE1KO/XBP1KO (double KO; DKO) naive B cells were stimulated
with 20 µg/ml LPS for a course of 3 d and immunoblotted. (B) WT, XBP1KO, S729A, and S729A/XBP1KO naive B cells were stimulated with LPS for a course
of 3 d and immunoblotted. Immunoblot data shown in this figure are representative of three independent experiments. (C) Naive B cells from WT, XBP1KO,
DKO, and S729A/XBP1KO mice were stimulated with LPS for 3 d and lysed for purification of total RNA and synthesis of cDNA. The levels of μS mRNA were
measured by quantitative RT-PCR, which was performed in triplicate for each sample. Data were normalized to UBC (a house-keeping gene) and are shown
as means ± SD. (D) 2-d LPS-stimulated XBP1KO and S729A/XBP1KO B cells were further stimulated with LPS for an additional 8, 16, and 24 h. The levels of μS
mRNA were measured by quantitative RT-PCR. (E and F) WT, XBP1KO, DKO, and S729A/XBP1KO B cells were stimulated with LPS for 3 d. The mRNA levels of
Tapbp1 (E) and Hgsnat (F) were measured by quantitative RT-PCR. (G–M) IRE1−/− MEFs were transfected with pcDNA3.1 plasmids carrying full-length mouse
IRE1 cDNA (WT) or carrying the S729D or S729E mutation. The mRNA levels of Ergic3 (G), Scara3 (H), pdgfrb (I), Col6a1 (J), Tapbp1 (K), Bloc1S1 (L), and Hgsnat
(M) were measured by quantitative RT-PCR 48 h after transfection. Data are shown as means ± SD. All quantitative RT-PCR data shown are representative of
three independent experiments.

By transfecting insect cells with the cytoplasmic domain (aa
547–977) of human IRE1, IRE1 was shown to be phosphorylated
at S551, S562, S724, S726, S729, and T973 (Prischi et al., 2014).
Although S724, S726, and S729 are located in the activation loop of
human IRE1 and are hypothesized to be critical for regulating the
RNase activity of IRE1, IRE1 carrying S724A/S726A/S729A triple
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mutations can still robustly splice the XBP1 mRNA (Prischi et al.,
2014), suggesting that phosphorylation of mammalian IRE1 at the
activation loop is not required for splicing of the XBP1 mRNA.
Yeast Ire1 carrying all 5 phosphorylation mutations in the activation loop can still splice HAC1 mRNA (Armstrong et al., 2017).
When HT1080 cells were transfected with the S724A/S726A double mutant or the S724A/S726A/S729A triple mutant, the two
mutants showed similar effects in splicing XBP1 mRNA, leading
to the conclusion that the RNase activity of human IRE1 can only
be enhanced by phosphorylation of S724 and S726 (Prischi et al.,
2014). IRE1 in LPS-stimulated B cells does not require phosphorylation to activate XBP1 (Fig. 1, H and J). When compared with
LPS-stimulated WT B cells, LPS-stimulated S729A B cells do not
exhibit changes in the mRNA levels of XBP1s and RIDD substrates
(Fig. 8, C–J), further suggesting that IRE1 does not require phosphorylation at S729 to splice or cleave mRNAs in LPS-stimulated
WT B cells. Although Tg induces phosphorylation of IRE1 only
at S729 in LPS-stimulated B cells, SubAB and DTT can induce
phosphorylation at S729 and other sites in these cells (Fig. 6 E).
However, S729A mutation completely blocks IRE1’s ability to
Tang et al.
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further up-regulate XBP1s to respond to any of these ER stress
conditions (Fig. 6). We propose that S729 may be the first residue undergoing phosphorylation in the activation loop of IRE1
in LPS-stimulated WT B cells in response to SubAB treatment as
indicated by no IRE1 band shift in LPS-stimulated S729A B cells at
the early time points of the pulse-chase experiment (Fig. 4 A). In
addition, the slightly decreased levels of XBP1s in LPS-stimulated
S729A B cells (Fig. 5, A, C, and D; and Figs. 6 D and 7 B) suggest that
XBP1s may be directly or indirectly stabilized by IRE1 and that the
replacement of the polar S729 residue by a hydrophobic alanine
may compromise such a stabilizing effect.
Phosphorylation at S729 of IRE1 occurs in B cells lacking
XBP1s or exposed to SubAB (Fig. 1, F, H, and I). Both XBP1 deficiency and SubAB treatment lead to degradation of RIDD substrates in B cells, and such degradation can be blocked by S729A
mutation (Fig. 7, B–F; and Fig. 8, D and F–J). Tu does not induce
phosphorylation of S729 on IRE1, although it can induce the
expression of XBP1s by activating other phosphorylation sites
(Fig. S1, C, D, and J). As expected, Tu fails to induce RIDD of μS
mRNA in B cells (Fig. 8 E). Together with data showing that RIDD
Journal of Cell Biology
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Figure 8. SubAB induces RIDD in B cells. (A–D) 2-d LPS-stimulated WT and S729A B cells were exposed to 1 nM SubAB for 24 h. The mRNA levels of Hspa5
(A), Pdia4 (B), XBP1s (C), and μS (D) were measured by quantitative RT-PCR. (E) 2-d LPS-stimulated WT and S729A B cells were exposed to 5 µg/ml Tu for 24 h.
The μS mRNA levels were measured by quantitative RT-PCR. (F–J) 2-d LPS-stimulated WT and S729A B cells were exposed to 1 nM SubAB for 24 h. The mRNA
levels of the indicated genes were measured by quantitative RT-PCR. (K and L) Naive B cells from WT and XBP1KO mice were stimulated with LPS for 3 d. Some
XBP1KO B cells were incubated with 20 µM B-I09 (K) or 5 µM KIRA6 (L) in the last 24 h of LPS stimulation. The μS mRNA levels were measured by quantitative
RT-PCR. Data are shown as means ± SD. Quantitative RT-PCR data are representative of three independent experiments.
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is readily observed in IRE1−/− MEFs transfected with phosphomimetic mutants of IRE1 (Fig. 7, G–M), phosphorylation at S729 is
indispensable for RIDD.
In addition to regulating RIDD, phosphorylation at S729 can
enhance the RNase activity of IRE1 in splicing XBP1 (Fig. 10).
Although XBP1 splicing can occur in LPS-stimulated S729A B cells
(Fig. 5, A and C; and Figs. 6 D and 7 B), these B cells fail miserably in their response to secondary ER stress insults (Fig. 6, A–D;
and Fig. S5). We propose that S729 phosphorylation triggers
enhanced XBP1 splicing and RIDD, which can together relieve
ER stress in B cells by synthesizing more lipids and chaperones
to increase the folding capacity of the ER via enhanced XBP1
splicing and by reducing the production of μS chains and other
proteins via RIDD. In B cells that lack XBP1s, S729 phosphorylation allows activation of RIDD to reduce the amounts of newly

synthesized unfolded μS chains to enter the ER, thus protecting
XBP1-deficient B cells from proteotoxicity (Fig. 10). We showed
previously that SubAB can cleave BiP in B cells, and the resultant C-terminal substrate-binding domain of BiP can efficiently
sequester the κ light chain together with μ heavy chains inside
B cells (Hu et al., 2009b); here, SubAB-induced S729 phosphorylation can activate RIDD to reduce the production of secretory μ
chains (Fig. 8 D), representing another tactic of Shiga-toxigenic
E. coli in dismantling the host’s B cell function.
The IRE1 RNase inhibitor B-I09 inhibits IRE1 from splicing
XBP1 and engaging RIDD (Figs. 2 A, 4 C, 6 A, and 8 K; Tang et al.,
2014), supporting that the “same” RNase domain of IRE1 splices
XBP1 mRNA and cleaves μS mRNA. We hypothesize that phosphorylation at S729 might allow dimeric or oligomeric IRE1 to
interact with other proteins in the UPRosome (Hetz et al., 2011;
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Figure 9. Immunized S729A mice produce
increased serum levels of IgM and IgG2b.
(A–C) Serum levels of anti–NP IgM in WT,
XBP1KO, S729A, and S729A/XBP1KO mice (n = 5
per group) were determined by ELISA on day 3
(A), day 6 (B), and day 9 (C) after immunization
with NP-Ficoll on day 0. (D and E) On day 9,
NP-Ficoll–immunized mice were sacrificed to
analyze for anti–NP IgM–secreting plasma cells in
the bone marrow by ELISPOT (D). Bone marrow
cells isolated from immunized mice were stained
with CD138-PE, B220-BV605, and XBP1s–Alexa
Fluor 647. Gated CD138+ populations were analyzed for the expression of XBP1s (E). (F) Serum
levels of anti–HEL IgG2b in WT and S729A mice
immunized with HEL/CFA followed by 3 boosts
with HEL/IFA were determined by ELISA. Data
are shown as means ± SEM.

Figure 10. A model depicting S729 phosphorylation of IRE1 enhancing the expression of XBP1s and activating RIDD in B cells.
Tang et al.
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Woehlbier and Hetz, 2011), resulting in further assembly of its
RNase domains to assume a more “relaxed and promiscuous” conformation to enhance XBP1 splicing and cleave RIDD substrates.
Because S729 phosphorylation of IRE1 is critical in regulating
RIDD, small molecules that specifically inhibit S729 phosphorylation can be useful tools in interrogating the biology of RIDD
in human diseases. KIRA6 is one such inhibitor because it rapidly inhibits S729 phosphorylation of IRE1 and suppresses RIDD
without affecting the levels of XBP1s (Figs. 2 F, 8 L, and S2, A–D).

Materials and methods

Tang et al.
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Mice
The S729A knock-in mice, together with XBP1f/f, CD19Cre/
XBP1f/f, IRE1f/f (provided by D. Fang, Northwestern University, Chicago, IL), CD19Cre/IRE1f/f, IRE1f/f/XBP1f/f, CD19Cre/
IRE1f/f/XBP1f/f, S729A/XBP1f/f, and S729A/CD19Cre/XBP1f/f
mice were maintained at our animal facility strictly following
the guidelines provided by the Wistar Institute Committee
on Animal Care.
Study approval
All experiments involving the use of mice were performed following protocols approved by the Institutional Animal Care and
Use Committee at the Wistar Institute.
Purification of mouse B cells
Splenocytes were obtained from mice by mashing the spleens
through cell strainers followed by RBC lysis (Sigma-Aldrich).
Mouse B cells were purified from mouse spleens by negative
selection using CD43 (Ly48) or pan-B magnetic beads (Miltenyi
Biotec), according to the manufacturer’s instructions.
Mass spectrometry
Protein bands were stained with Coomassie brilliant blue G-250,
excised, reduced, and alkylated. In-gel proteolytic digestion with
trypsin, chymotrypsin, or both was used to prepare samples for
peptide sequencing with reverse-phase LC-MS/MS using Dionex
ultraperformance liquid chromatography (Thermo Fisher Scientific) interfaced with an electrospray hybrid, linear-ion trap–
orbital ion trap (LTQ Orbitrap; Thermo Fisher Scientific) mass
spectrometer. Protonated peptide molecules were measured in
positive ion mode in the survey scan (MS1), before selection of
the top seven ion signals for tandem mass spectrometry. Fragment ion mass spectra obtained from LC-MS/MS were submitted to SEQUEST (Thermo Fisher Scientific) and MASCOT software (Matrix Science) searches for entries of the appropriate
species in the UniProt database. In addition to mass tolerances
appropriate to the instrument, two missed cleavages and variable modifications (Ser/Thr/Tyr phosphorylation and Met
oxidation) were included in the search parameters. Matched
sequences were summarized in Scaffold software (Proteome
Software); single peptide matches for protein identifications
and all phosphorylated peptides were further verified by manual
inspection of the tandem mass spectrometry spectra and relatively quantified using XICs.
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Generation and maintenance of the S729A
knock-in mouse model
10 µg of the targeting vectors were transfected by electroporation of C57BL/6 (B6) embryonic stem (ES) cells. After selection
with the G418 antibiotic, surviving clones were expanded for PCR
analysis to identify recombinant ES clones. Primers designed
within the Neo cassette (forward) and downstream of the short
homology arm (reverse) were used for screening by PCR to identify positive clones, which were then selected for expansion and
reconfirmed for short homology arm integration. Sequencing
was performed on purified PCR DNA to confirm the presence of
the point mutation. Secondary confirmation of positive clones
identified by PCR was performed using Southern blotting analysis to confirm the integration of 3′ and 5′ homology arms. In brief,
restriction-digested DNA was electrophoretically separated on a
0.8% agarose gel, transferred to a nylon membrane, and hybridized with a probe targeted against the Neo cassette. The probe
includes part of the Neo sequence as well as the mouse genomic
sequence and hybridizes to the Neo cassette and the genomic
sequence to generate two bands (targeted and WT) on the blot.
DNA from the B6 mouse strain was used as the WT control. Each
clonal cell culture was sampled before injection and had an equal
passage number to the injected cells. For each clone, 20 metaphase spreads were analyzed, and the percent euploidy in each
culture was calculated following the Cold Spring Harbor Laboratory’s chromosome counting protocol of ignoring metaphase
spreads with <39 chromosomes. All clones passed the required
70% euploid cutoff. Targeted ES cells were microinjected into
BALB/c blastocysts. Resulting chimeras with a high percentage
black-coat coloring were mated to C57BL/6 flippase (FLP) mice
to remove the Neo cassette, which is flanked by FLP recognition
target sites. Tail DNA samples from pups with black coat coloring were screened for the deletion of the Neo cassette by PCR
using designed primers. Again, sequencing was performed on
purified PCR DNA to confirm the presence of the desired point
mutation. We also confirmed the absence of the FLP transgene
and reconfirmed the integration of the short homology arm by
PCR using specific primers. The mice, confirmed for somatic Neo
deletion, were mated to WT B6 mice to generate germline Neodeleted mice, which were again genotyped for the presence of Neo
deletion and the absence of the FLP transgene. These germline
Neo-deleted mice were mated to each other to generate homozygous mice. Homozygous male S729A mice must be crossed with
heterozygous female S729A mice to maintain the S729A mouse
colony. We set up >12 breeding pairs using homozygous S729A

female mice, but these homozygous S729A female mice never
gave birth to pups, consistent with a previous study showing a
critical role for IRE1 in the placenta during pregnancy (Iwawaki
et al., 2009). Histological examinations of the female reproductive organs in S729A mice showed the normal ovarian cycle with
follicles of every stage identified. The S729A male and female
pups are born at a normal Mendelian ratio. In the S729A mouse
colony, ∼50% pups carry homozygous S729A alleles.

Flow cytometric analysis
Single-cell suspensions from spleens, bone marrow, or peripheral lymph nodes were blocked for 30 min using FBS. Cell-surface
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Antibodies and reagents
Rabbit polyclonal antibodies against recombinant mouse IRE1
(aa 21–445) and a phospho-S729 peptide were generated and
affinity purified. Polyclonal antibodies against BiP/GRP78 and
PDI were also generated in rabbits. The following antibodies
were obtained commercially: IRE1 (Cell Signaling Technology),
XBP1s (Cell Signaling Technology), GRP94 (Stressgen), p97
(Fitzgerald Industries), μ (SouthernBiotech), κ (SouthernBiotech), phospho-ERK1/2 (Cell Signaling Technology), ERK1/2
(Cell Signaling Technology), phospho–nuclear factor κ–light
chain enhancer of activated B cells (NF-κB) p105 (Cell Signaling
Technology), phospho–NF-κB p65 (Cell Signaling Technology),
and caspase 3 (Cell Signaling Technology). LPS (Sigma-Aldrich), DTT (Sigma-Aldrich), BFA (Cell Signaling Technology),
CpG-1826 oligodeoxynucleotides (TIB-Molbiol), Tu (Enzo Life
Sciences), Tg (Enzo Life Sciences), KIRA6 (EMD Millipore),
staurosporine (EMD Millipore), imatinib (EMD Millipore),
sunitinib (Sigma-Aldrich), MG-132 (Enzo Life Sciences), Z-VADFMK (Enzo Life Sciences), chloroquine (Cell Signaling Technology), and NH4Cl (Sigma-Aldrich) were also purchased from
commercial sources. Native and mutant SubAB were purified
as described previously (Paton et al., 2004; Talbot et al., 2005).
Shiga toxin 1, Shiga toxin 2, cholera toxin, and pertussis toxin
were purchased from the List Biological Laboratories. We developed and chemically synthesized the IRE1 RNase inhibitor B-I09
(Tang et al., 2014).
Cell culture
Purified naive mouse B cells, mouse 5TGM1 myeloma cells (provided by L.A. Hazlehurst, West Virginia University, Morgantown,
WV), mouse A20 B cell lymphoma cells (ATCC), and human H929
myeloma cells (ATCC) were cultured in the RPMI-1640 medium
(Gibco) supplemented with 10% heat-inactivated FBS, 2 mM
l-glutamine, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, 1 mM sodium pyruvate, 0.1 mM nonessential
amino acids, and 0.1 mM β-mercaptoethanol (β-ME). 5TGM1
cells were tested for the secretion of Ig and the surface expression of plasma cell marker CD138 every 6 mo. All cell lines were
negative for mycoplasma contamination.
Tang et al.
Phosphorylation at S729 of IRE1 regulates RIDD

Site-directed mutagenesis and transfection
IRE1−/− MEFs were provided by D. Ron (University of Cambridge,
Cambridge, England, UK) and cultured in DMEM supplemented
with 10% FBS. Full-length mouse IRE1 cDNA was cloned into
pcDNA3.1+ plasmid between EcoRI and NotI restriction sites.
Mutagenesis was performed according to the manufacturer's
instructions using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies). The sense oligonucleotides used
for S729D and S729E were as follows, with the altered codons
underlined: 5′-GGCACAGTTTCAGCCGCCGTGATGGGGTACCT
GGC-3′ (S729D) and 5′-GGCACAGTTTCAGCCGCCGTGAGGGGGTA
CCTGGC-3′ (S729E). IRE1−/− MEFs were transfected using Lipofectamine 3000 reagent (Thermo Fisher Scientific) according to
the manufacturer’s instructions.
Protein isolation, immunoprecipitation, dephosphorylation,
and immunoblotting
Cells were lysed in radioimmunoprecipitation assay buffer
(10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, and 1 mM EDTA) supplemented with
protease inhibitors (Roche) and phosphatase inhibitors. Protein
concentrations were determined by bicinchoninic acid assays
(Thermo Fisher Scientific). IRE1 was immunoprecipitated with
an anti–mouse IRE1 antibody and protein G–Sepharose beads
(Sigma-Aldrich). Bead-bound IRE1 was dephosphorylated using
λPPase (New England Biolabs, Inc.) or CIP (New England Biolabs,
Inc.). Proteins were boiled in SDS-PAGE sample buffer (62.5 mM
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% bromophenol
blue) with β-ME, analyzed by SDS-PAGE, and transferred to
nitrocellulose membranes, which were then blocked in 5% nonfat milk (wt/vol in PBS) and immunoblotted with the indicated
primary antibodies and appropriate HRP-conjugated secondary
antibodies. Immunoblots were developed with Western Lightning chemiluminescence reagent (Perkin-Elmer).
Pulse-chase experiments, immunoprecipitation, and protein
dephosphorylation
Cells were starved in methionine- and cysteine-free media containing dialyzed FBS for 1 h and pulse-labeled with 250 µCi/ml
[35S]methionine and [35S]cysteine (Perkin-Elmer) for the indicated times. After labeling, cells were incubated in the chase
medium containing unlabeled methionine (2.5 mM) and cysteine (0.5 mM). At the end of each chase interval, cells were lysed
in radioimmunoprecipitation assay buffer containing protease
inhibitors. Precleared lysates were incubated with an anti–mouse
IRE1 antibody and protein G–Sepharose beads. To enzymatically
remove the phosphate group, bead-bound IRE1 was incubated
with λPPase. Samples were boiled in SDS-PAGE sample buffer
(62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% bromophenol blue) with β-ME, analyzed by SDS-PAGE, and visualized by autoradiography.
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staining was achieved by incubating cells at 4°C for 30 min with
fluorescence-conjugated anti–mouse antibodies (clone; source):
XBP1s–Alexa Fluor 647 (Q3-695; BD), XBP1s-phycoerythrin (PE;
Q3-695; BD), B220–Alexa Fluor 488 (RA3-6B2; BioLegend),
B220-BV605 (RA3-6B2; BioLegend), CD43-PE (eBioR2/60;
eBioscience), CD19–Alexa Fluor 647 (6D5; BioLegend), IgMPE-Cy7 (RMM-1; BioLegend), IgD-FITC (11-26c.2a; BioLegend),
GL7-PE (GL7; BioLegend), AA4.1-PE-Cy7 (AA4.1; BioLegend),
CD1d-PerCP-Cy5.5 (1B1; BioLegend), CD23-FITC (B3B4; BioLegend), CD3-APC-Cy7 (145-2C11; BioLegend), CD4-BV605 (RM4-5;
BioLegend), CD8α-PE-Cy7 (53–6.7; BioLegend), and CD138-PE
(281–2; BioLegend). Viability staining was accomplished using
DAPI exclusion during acquisition. Acquisition of B, T, and dendritic cell populations was performed on an LSRII cytometer
(BD) harboring a custom configuration for the Wistar Institute.
Cytometry data were analyzed using FlowJo software (7.6.1;
Tree Star Inc.).

RT-PCR
Total RNA was isolated with TRIzol reagent (Invitrogen). cDNA
was synthesized from RNA with Superscript II reverse transcription (Invitrogen). The following sets of primers were used
together with Platinum Taq DNA polymerase (Invitrogen) in PCR
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Immunization
Mice were intraperitoneally immunized with HEL (100 µg/
mouse; Sigma-Aldrich) mixed in CFA or IFA (Sigma-Aldrich) or
with NP55-aminoethylcarboxymethyl-Ficoll (40 µg/mouse; LGC
Biosearch Technologies) in PBS.
ELISA and enzyme-linked immunospot (ELISPOT) assay
For ELISA, plates were coated with HEL or NP23-BSA. ELISA
analyses of mouse IgM, IgG, IgG1, and IgG2b in immunized mouse
sera were achieved with HRP-conjugated secondary antibodies
against each mouse antibody isotype (SouthernBiotech) and
3,3′,5,5′-tetramethylbenzidine liquid substrate system (Sigma-Aldrich). For ELISPOT assay, MultiScreen-IP filter plates
(EMD Millipore) were coated with NP23-BSA. Bone marrow cells
were serially diluted across the plate and then incubated for 16 h
at 37°C. HRP-conjugated goat anti–mouse IgM antibodies (SouthernBiotech) diluted in blocking buffer (10% FBS in PBS) were
added. Spots were detected with the 3,3′,5,5′-tetramethylbenzidine substrate for ELISPOT (Mabtech) and scanned and counted
with an ImmunoSpot Analyzer (Cellular Technology Ltd.).
Statistics
For comparison of percentages of cell populations among experimental groups, data were graphed as means ± SEM. Statistical
significance (P < 0.05) was determined by Student’s t test.
Online supplemental material
Fig. S1 shows that Tg, but not Tu, BFA, or MG132, induces IRE1 to
undergo phosphorylation at S729. Fig. S2 shows that KIRA6 rapidly
suppresses SubAB-induced S729 phosphorylation of IRE1 and that
Shiga toxins, cholera toxin, and pertussis toxin do not induce S729
phosphorylation even when used at high concentrations. Fig. S3
documents the generation of the S729A mouse model and shows
that B cells develop normally in the bone marrow of unimmunized
S729A mice and that after immunization, the percentages of pro–
and mature B cells increase in the bone marrow of S729A mice.
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Fig. S4 documents normal B and T cell percentages in the spleens
and lymph nodes of unimmunized S729A mice and shows that
after immunization, the percentages of CD19+ B cells decrease
in the lymph nodes, whereas the percentages of CD4+ and CD8+
T cells increase in the spleens and lymph nodes of S729A mice.
Fig. S5 shows that LPS-stimulated B cells from S729A mice fail to
respond to Tg or SubAB by enhancing the expression of XBP1s.
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